From today, the Generic Medicines Industry Association will be known as the Generic and Biosimilar Medicines Association. After patents expire on brand name medicines, affordable generic and biosimilar medicines deliver the same health benefits to patients while also providing savings to taxpayers and the government, GBMA says. This means more patients can have access to
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.